Clinical Research Directory
Browse clinical research sites, groups, and studies.
Fungal Infections During and After the SARS-CoV-2 Pandemic: A Retrospective Comparison
Sponsor: Bekir Sami Uyanık
Summary
his study aims to retrospectively compare fungal positivity rates between the SARS-CoV-2 pandemic and the post-pandemic periods. During the pandemic, Candida species had a positivity rate of 17.36%, and Aspergillus had a rate of 2.22%. Post-pandemic, these rates decreased to 9.29% and 1.00%, respectively. The overall fungal positivity rate decreased from 9.15% during the pandemic to 5.13% post-pandemic. Statistical analysis revealed a significant decrease in fungal positivity rates post-pandemic (p \< 0.01). These findings underscore the effectiveness of post-pandemic healthcare interventions and infection control strategies.
Official title: Comparative Retrospective Analysis of Fungal Positivity Rates During and Post-SARS-CoV-2 Pandemic Periods
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
1441
Start Date
2024-06-01
Completion Date
2024-07-30
Last Updated
2024-07-05
Healthy Volunteers
Yes
Conditions
Interventions
Culture, İsolation
Data on patient demographics, clinical conditions, and fungal infection positivity rates were extracted from hospital records. Fungal positivity rates were calculated based on laboratory results and presented as percentages. Statistical analyses were performed using the Chi-Square test, and p-values were reported.
Locations (1)
Hisar Hospital Intercontinental
Istanbul, Turkey (Türkiye)